The market size for penicillins and streptomycins in dosage, expressed in value per capita in the UK, is projected to decrease from $10.66 in 2024 to $9.92 by 2028. This represents a year-on-year decline of about 1.8% annually from 2024 onwards. The data illustrates a downward trend in market value, with an average annual decrease, as captured by the CAGR, of approximately 1.5% over the five-year period ending in 2028. From 2023 to 2024, the trend also followed a downward trajectory.

Future trends to watch for include:

Potential impacts of pharmaceutical innovations and generic drug entries, which may further influence market dynamics.
Changes in healthcare regulations and antibiotic stewardship programs that could affect demand and prescriptions.
Economic factors such as inflation and changes in consumer purchasing power that may impact market size.